Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitric Acid SCHEMBL1274754 | 1.00 | — | — | |
| Nitric Acid SCHEMBL27386902 | 0.95 | — | — | |
| Nitric Acid SCHEMBL28250940 | 0.95 | — | — | |
| Nitric Acid SCHEMBL28509292 | 0.95 | — | — | |
| Nitric Acid SCHEMBL28213451 | 0.95 | — | — | |
| Nitric Acid SCHEMBL11313025 | 0.95 | CA5A (0.89) | — | |
| Nitric Acid SCHEMBL11220478 | 0.95 | CA5A (0.89) | — | |
| Nitric Acid SCHEMBL11758696 | 0.95 | CA5A (0.89) | — | |
| Nitric Acid SCHEMBL310885 | 0.95 | — | — | |
| Nitric Acid SCHEMBL8101974 | 0.95 | CA5A (0.89) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107607432-A | The assay method of tungstic acid in high molybdenum high phosphorus tungsten ore | 赣州华兴钨制品有限公司 | 2018-01-19 | — | — | CN | claimed |
| CN-220478273-U | Portable style water filter equipment | 江西贯一检测技术有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-117105253-A | Method for preparing high added value calcium carbonate by wet carbonization of metallurgical slag rich in free CaO | 郑州中科新兴产业技术研究院 | 2023-11-24 | — | — | CN | disclosed |
| CN-110078098-A | A kind of impurity removal process preparing high pure nitric acid potassium | 澧县腾飞化工有限公司 | 2019-08-02 | — | — | CN | disclosed |
| CN-109289523-A | A kind of boat diesel engine exhaust gas integrated purification device | 江苏海事职业技术学院 | 2019-02-01 | — | — | CN | disclosed |
| CN-108568311-A | A kind of method of catalyst and synthesis gas directly conversion ethylene processed | 中国科学院大连化学物理研究所 | 2018-09-25 | — | — | CN | disclosed |
| CN-107607432-A | The assay method of tungstic acid in high molybdenum high phosphorus tungsten ore | 赣州华兴钨制品有限公司 | 2018-01-19 | — | — | CN | disclosed |
| US-20100137448-A1 | Methods for Treating Neuropsychiatric Disorders with NMDA Receptor Antagonists | NEUROMOLECULAR, INC. | 2010-06-03 | — | — | US | disclosed |
| US-20080193358-A1 | Method for the Production of a Catalytically Active Mineral on the Basis of a Tectosilicate | S & B INDUSTRIAL MINERALS GMBH (DE) | 2008-08-14 | — | — | US | disclosed |
| US-20080183003-A1 | AMINOADAMANTANE DERIVATIVES AS THERAPEUTIC AGENTS | ADAMAS PHARMACEUTICALS, INC. (US) | 2008-07-31 | — | — | US | disclosed |
| US-20040122090-A1 | Methods for treating neuropsychiatric disorders with nmda receptor antagonists | NEUROMOLECULAR PHARMACEUTICALS INC. | 2004-06-24 | — | — | US | disclosed |
| US-20040029929-A1 | Aminoadamantane derivatives as therapeutic agents | WANG YUQIANG (US) | 2004-02-12 | — | — | US | disclosed |
| EP-1351670-A1 | METHODS FOR TREATING NEUROPSYCHIATRIC DISORDERS WITH NMDA RECEPTOR ANTAGONISTS | Neuromolecular Inc. (US) | 2003-10-15 | — | — | EP | disclosed |
| US-6620845-B2 | For therapy and prophylaxis of neurological diseases | NEUROMOLECULAR, INC. | 2003-09-16 | — | — | US | disclosed |
| WO-2002045710-A9 | METHODS FOR TREATING NEUROPSYCHIATRIC DISORDERS WITH NMDA RECEPTOR ANTAGONISTS | NEUROMOLECULAR INC (US) | 2003-04-24 | — | — | WO | disclosed |
| US-20030008889-A1 | Aminoadamantane derivatives as therapeutic agents | PANORAMA RESEARCH, INC. | 2003-01-09 | — | — | US | disclosed |
| EP-1259477-A1 | AMINOADAMANTANE DERIVATIVES AS THERAPEUTIC AGENTS | PANORAMA RESEARCH, INC. (US) | 2002-11-27 | — | — | EP | disclosed |
| US-6444702-B1 | CENTRAL NERVOUS SYSTEM DISORDERS | NEUROMOLECULAR, INC. | 2002-09-03 | — | — | US | disclosed |
| WO-2002045710-A1 | METHODS FOR TREATING NEUROPSYCHIATRIC DISORDERS WITH NMDA RECEPTOR ANTAGONISTS | NEUROMOLECULAR INC. (US) | 2002-06-13 | — | — | WO | disclosed |
| WO-2001062706-A1 | AMINOADAMANTANE DERIVATIVES AS THERAPEUTIC AGENTS | PANORAMA RESEARCH, INC. (US) | 2001-08-30 | — | — | WO | disclosed |